MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection ProgramDecember 22, 2020 MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor DemandDecember 17, 2020 MagicMed Industries Announces $2.5 Million Unit Offering Led by Gravitas SecuritiesNovember 10, 2020 MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™October 30, 2020 Psychedelic Medicine Association Announced Globally: MagicMed Industries Joins as Founding MemberSeptember 17, 2020 MagicMed Industries Closes Oversubscribed Private Placement for $1,642,880 with Mackie Research Capital CorporationSeptember 2, 2020 MagicMed Industries Inc. Announces Brokered Private Placement with Mackie Research Capital CorporationJuly 20, 2020 MagicMed Industries Files First Psychedelic Derivative PatentJuly 9, 2020
